Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Neutropenia × Levofloxacin × Clear all

Phase

Status

Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neutropenia 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Hemorrhage 1 Febrile Neutropenia 1 Anastomotic Leak 1

Interventions

trifluridine tipiracil drug combination 1 Levofloxacin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07528417 2026-04-14

MYELO-CAN:ABX

University of Manitoba

Phase 2 Not yet recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡